RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Adverum Biotechnologies EBIT 2024

Adverum Biotechnologies EBIT

-123.08 M USD

Adverum Biotechnologies Dividend yield

Ticker

ADVM

ISIN

US00773U1088

WKN

A2AJW8

In 2024, Adverum Biotechnologies's EBIT was -123.08 M USD, a -0.58% increase from the -123.79 M USD EBIT recorded in the previous year.

The Adverum Biotechnologies EBIT history

YEAREBIT (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-

Adverum Biotechnologies Aktienanalyse

What does Adverum Biotechnologies do?

Adverum Biotechnologies Inc. is a California-based publicly traded company that focuses on the development of gene therapy solutions for eye diseases. It was founded in 2006 under the name Avalanche Biotechnologies and changed its name to Adverum Biotechnologies in 2016. The company has formed several partnerships with major pharmaceutical companies such as Pfizer and Regeneron. Adverum Biotechnologies specializes in developing gene therapies for various eye diseases, particularly retinal diseases like wet age-related macular degeneration (AMD) and diabetic retinopathy (DR). The company's goal is to restore functionality to the eye retina through its gene therapies. Adverum Biotechnologies has applied for multiple patents for its gene therapy platform technology and focuses on vector manufacturing for gene therapy. The company operates in several departments including research and development, manufacturing, and business development. Its main products in clinical development are AAVCAGsCD59 for wet AMD and ADVM-022 for diabetic retinopathy. Adverum Biotechnologies also has a pipeline of products in preclinical development for retinal diseases such as retinitis pigmentosa and X-linked retinoschisis. Overall, Adverum Biotechnologies is a rising company in the field of gene therapy and eye medicine, with a strong pipeline of products in both clinical and preclinical stages. The company's strategic partnerships and experienced research team position it well to develop gene therapies for various eye diseases and provide improved solutions for treating retinal diseases. Adverum Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Adverum Biotechnologies's EBIT

Adverum Biotechnologies's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Adverum Biotechnologies's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Adverum Biotechnologies's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Adverum Biotechnologies’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Adverum Biotechnologies Stock

How much did Adverum Biotechnologies achieve in EBIT for the current year?

In the current year, Adverum Biotechnologies has achieved an EBIT of -123.08 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Adverum Biotechnologies.

How has the EBIT of Adverum Biotechnologies developed in recent years?

The EBIT of Adverum Biotechnologies has increased by -0.577% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Adverum Biotechnologies?

The EBIT of Adverum Biotechnologies is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Adverum Biotechnologies pay?

Over the past 12 months, Adverum Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Adverum Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Adverum Biotechnologies?

The current dividend yield of Adverum Biotechnologies is .

When does Adverum Biotechnologies pay dividends?

Adverum Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Adverum Biotechnologies?

Adverum Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Adverum Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Adverum Biotechnologies located?

Adverum Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adverum Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adverum Biotechnologies from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Adverum Biotechnologies pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Adverum Biotechnologies in the year 2023?

In the year 2023, Adverum Biotechnologies distributed 0 USD as dividends.

In which currency does Adverum Biotechnologies pay out the dividend?

The dividends of Adverum Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Adverum Biotechnologies

Our stock analysis for Adverum Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adverum Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.